Welcome to LookChem.com Sign In|Join Free

CAS

  • or

21302-43-2

Post Buying Request

21302-43-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

21302-43-2 Usage

Description

5-Amino-8-quinolinol dihydrochloride is a crystalline powder that serves as an important intermediate in the synthesis of various organic compounds and pharmaceuticals.

Uses

Used in Pharmaceutical Industry:
5-Amino-8-quinolinol dihydrochloride is used as a key intermediate for the synthesis of several pharmaceutical compounds, including 5-acetamido-8-hydroxyquinoline hydrochloride, 5-(p-tolylsulfonylimino)quinolin-8-one, and 5,8-quinolinesemiquinone via ferric chloride oxidation. These synthesized compounds have potential applications in the development of new drugs and therapies.
Used in Organic Synthesis:
5-Amino-8-quinolinol dihydrochloride is used as a versatile building block in organic synthesis for the preparation of various quinoline-based derivatives. Its unique structure allows for further functionalization and modification, making it a valuable component in the synthesis of complex organic molecules and potential drug candidates.
Used in Research and Development:
5-Amino-8-quinolinol dihydrochloride is utilized in research and development laboratories for the study of quinoline chemistry, its derivatives, and their potential applications in various fields, such as medicinal chemistry, materials science, and agrochemicals. Its use in research helps to advance the understanding of quinoline-based compounds and their properties, leading to the discovery of new applications and improvements in existing ones.

Check Digit Verification of cas no

The CAS Registry Mumber 21302-43-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,3,0 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 21302-43:
(7*2)+(6*1)+(5*3)+(4*0)+(3*2)+(2*4)+(1*3)=52
52 % 10 = 2
So 21302-43-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H8N2O.2ClH/c10-7-3-4-8(12)9-6(7)2-1-5-11-9;;/h1-5,12H,10H2;2*1H

21302-43-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A1005)  5-Amino-8-hydroxyquinoline Dihydrochloride  >98.0%(HPLC)(N)

  • 21302-43-2

  • 5g

  • 1,190.00CNY

  • Detail
  • TCI America

  • (A1005)  5-Amino-8-hydroxyquinoline Dihydrochloride  >98.0%(HPLC)(N)

  • 21302-43-2

  • 25g

  • 4,190.00CNY

  • Detail
  • Aldrich

  • (305529)  5-Amino-8-hydroxyquinolinedihydrochloride  95%

  • 21302-43-2

  • 305529-1G

  • 482.04CNY

  • Detail
  • Aldrich

  • (305529)  5-Amino-8-hydroxyquinolinedihydrochloride  95%

  • 21302-43-2

  • 305529-5G

  • 1,608.75CNY

  • Detail

21302-43-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-aminoquinolin-8-ol,dihydrochloride

1.2 Other means of identification

Product number -
Other names 5-amino-quinolin-8-ol,dihydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21302-43-2 SDS

21302-43-2Relevant articles and documents

Quinone imines with a fused azine ring: I. Synthesis and hydrochlorination of 5-(p-tolylsulfonylimino)quinolin-8-one

Belov,Nichvoloda

, p. 93 - 96 (2004)

5-(p-Tolylsulfonylimino)quinolin-8-one was synthesized, and its reaction with hydrogen chloride was studied. The reaction leads to formation of 7-chloro-8-hydroxy-5-(p-tolylsulfonylamino)quinoline hydrochloride.

Substituted oxines inhibit endothelial cell proliferation and angiogenesis

Bhat, Shridhar,Shim, Joong Sup,Zhang, Feiran,Chong, Curtis Robert,Liu, Jun O.

supporting information; experimental part, p. 2979 - 2992 (2012/05/07)

Two substituted oxines, nitroxoline (5) and 5-chloroquinolin-8-yl phenylcarbamate (22), were identified as hits in a high-throughput screen aimed at finding new anti-angiogenic agents. In a previous study, we have elucidated the molecular mechanism of antiproliferative activity of nitroxoline in endothelial cells, which comprises of a dual inhibition of type 2 human methionine aminopeptidase (MetAP2) and sirtuin 1 (SIRT1). Structure-activity relationship study (SAR) of nitroxoline offered many surprises where minor modifications yielded oxine derivatives with increased potency against human umbilical vein endothelial cells (HUVEC), but with entirely different as yet unknown mechanisms. For example, 5-nitrosoquinolin-8-ol (33) inhibited HUVEC growth with sub-micromolar IC50, but did not affect MetAP2 or MetAP1, and it only showed weak inhibition against SIRT1. Other sub-micromolar inhibitors were derivatives of 5-aminoquinolin-8-ol (34) and 8-sulfonamidoquinoline (32). A sulfamate derivative of nitroxoline (48) was found to be more potent than nitroxoline with the retention of activities against MetAP2 and SIRT1. The bioactivity of the second hit, micromolar HUVEC and MetAP2 inhibitor carbamate 22 was improved further with an SAR study culminating in carbamate 24 which is a nanomolar inhibitor of HUVEC and MetAP2. The Royal Society of Chemistry 2012.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 21302-43-2